FindTrial
Sign In

Local estrogen creams to relieve vaginal symptoms of menopause

Comparative study of available vaginal creams for relieving Genitourinary symptoms. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097295
Enrollment
30
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

ABVIMS andRam Manohar Lohia Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consenting Postmenopausal patients (natural and surgical) diagnosed with Genitourinary syndrome of menopause.

Exclusion criteria

Exclusion criteria: Vaginal infection ( Candida/ Trichomoniasis). 2. Current Urinary tract infection. 3. Suspected malignancy, patient with undiagnosed vaginal bleeding. 4. Genital neoplasia, breast neoplasia or history of carcinoma breast/ endometrium in family. 5. Patient with history of thromboembolic events. 6. Active Liver disease, porphyria. 7. Allergic to estrogen. 8. Patient on menopausal hormonal therapy in the previous month.

Design outcomes

Primary

MeasureTime frame
To compare vaginal conjugated estrogen and vaginal estriol in relieving the symptoms of genitourinary syndrome of menopause (GSM).Timepoint: 4 weeks—

Secondary

MeasureTime frame
To assess the recurrence of symptoms after treatment.Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr Jaya Chawla

Dr Ram Manohar Lohia Hospital

renucam@yahoo.co.in9871867700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026